These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26585777)

  • 1. Immunosuppressive drugs affect induction of IFNy+ Treg in vitro.
    Daniel V; Trojan K; Opelz G
    Hum Immunol; 2016 Jan; 77(1):146-152. PubMed ID: 26585777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors.
    Meloni F; Morosini M; Solari N; Bini F; Vitulo P; Arbustini E; Pellegrini C; Fietta AM
    Int Immunopharmacol; 2006 Dec; 6(13-14):2002-10. PubMed ID: 17161354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helios expression and Foxp3 TSDR methylation of IFNy+ and IFNy- Treg from kidney transplant recipients with good long-term graft function.
    Trojan K; Unterrainer C; Weimer R; Bulut N; Morath C; Aly M; Zhu L; Opelz G; Daniel V
    PLoS One; 2017; 12(3):e0173773. PubMed ID: 28296931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.
    Fourtounas C; Dousdampanis P; Sakellaraki P; Rodi M; Georgakopoulos T; Vlachojannis JG; Mouzaki A
    Am J Nephrol; 2010; 32(1):1-9. PubMed ID: 20484893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFNγ+ Treg in-vivo and in-vitro represent both activated nTreg and peripherally induced aTreg and remain phenotypically stable in-vitro after removal of the stimulus.
    Daniel V; Trojan K; Adamek M; Opelz G
    BMC Immunol; 2015 Aug; 16():45. PubMed ID: 26268522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4(+)CD25(+)Foxp3(+)IFNγ(+) Treg are immunosuppressive in vitro and increase with intensity of the alloresponse in pretransplant MLC.
    Daniel V; Sadeghi M; Wang H; Opelz G
    Transpl Immunol; 2012 Oct; 27(2-3):114-21. PubMed ID: 22954802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
    Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V
    Front Immunol; 2021; 12():716559. PubMed ID: 34335631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil.
    Miroux C; Morales O; Ouaguia L; Aoudjehane L; Boleslawski E; Pancré V; de Launoit Y; Calmus Y; Conti F; Delhem N
    Transplant Proc; 2012 Nov; 44(9):2834-9. PubMed ID: 23146536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+CD25+Foxp3+IFN-γ+ human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically.
    Daniel V; Sadeghi M; Wang H; Opelz G
    Hum Immunol; 2011 Sep; 72(9):699-707. PubMed ID: 21664396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation.
    Lim DG; Koo SK; Park YH; Kim Y; Kim HM; Park CS; Kim SC; Han DJ
    Transplantation; 2010 Apr; 89(8):928-36. PubMed ID: 20305583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of CD4
    McRae JL; Chia JS; Pommey SA; Dwyer KM
    Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulatory T cells in kidney transplant recipients].
    Libetta C; Portalupi V; Margiotta E; Sepe V; Canevari M; Meloni F; Morosini M; Dal Canton A
    G Ital Nefrol; 2009; 26 Suppl 45():S54-7. PubMed ID: 19382095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFNy+ and IFNy- Treg subsets with stable and unstable Foxp3 expression in kidney transplant recipients with good long-term graft function.
    Trojan K; Unterrainer C; Aly M; Zhu L; Weimer R; Bulut N; Morath C; Opelz G; Daniel V
    Transpl Immunol; 2016 Oct; ():. PubMed ID: 27989714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro inhibition of IFNγ+ iTreg mediated by monoclonal antibodies against cell surface determinants essential for iTreg function.
    Daniel V; Sadeghi M; Wang H; Opelz G
    BMC Immunol; 2012 Aug; 13():47. PubMed ID: 22905732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ CD25+ Foxp3+ IFNγ+ CD178+ human induced Treg (iTreg) contribute to suppression of alloresponses by apoptosis of responder cells.
    Daniel V; Sadeghi M; Wang H; Opelz G
    Hum Immunol; 2013 Feb; 74(2):151-62. PubMed ID: 23017670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells and T cell depletion: role of immunosuppressive drugs.
    Noris M; Casiraghi F; Todeschini M; Cravedi P; Cugini D; Monteferrante G; Aiello S; Cassis L; Gotti E; Gaspari F; Cattaneo D; Perico N; Remuzzi G
    J Am Soc Nephrol; 2007 Mar; 18(3):1007-18. PubMed ID: 17287424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients.
    Vallotton L; Hadaya K; Venetz JP; Buehler LH; Ciuffreda D; Nseir G; Codarri L; Villard J; Pantaleo G; Pascual M
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):2025-33. PubMed ID: 21757642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical rejection and persistent immune regulation in kidney transplant patients.
    Hendrikx TK; Klepper M; Ijzermans J; Weimar W; Baan CC
    Transpl Immunol; 2009 Jul; 21(3):129-35. PubMed ID: 19398001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation.
    Wang H; Daniel V; Sadeghi M; Opelz G
    Transplant Proc; 2013 Jun; 45(5):1822-31. PubMed ID: 23769052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury.
    Ruggenenti P; Perico N; Gotti E; Cravedi P; D'Agati V; Gagliardini E; Abbate M; Gaspari F; Cattaneo D; Noris M; Casiraghi F; Todeschini M; Cugini D; Conti S; Remuzzi G
    Transplantation; 2007 Oct; 84(8):956-64. PubMed ID: 17989600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.